Kossan Rubber Industries Bhd (KSRBF)
USD 0.34
(26.19%)
USD 0.34
(26.19%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.24 Billion MYR | -1.79% |
| 2022 | 4.32 Billion MYR | -14.82% |
| 2021 | 5.07 Billion MYR | 39.79% |
| 2020 | 3.63 Billion MYR | 52.86% |
| 2019 | 2.37 Billion MYR | 10.66% |
| 2018 | 2.14 Billion MYR | 15.18% |
| 2017 | 1.86 Billion MYR | 20.18% |
| 2016 | 1.55 Billion MYR | 5.12% |
| 2015 | 1.47 Billion MYR | 14.47% |
| 2014 | 1.28 Billion MYR | 16.6% |
| 2013 | 1.1 Billion MYR | 11.73% |
| 2012 | 989.93 Million MYR | 21.85% |
| 2011 | 812.44 Million MYR | 4.52% |
| 2010 | 777.34 Million MYR | 12.9% |
| 2009 | 688.54 Million MYR | 5.33% |
| 2008 | 653.69 Million MYR | 21.76% |
| 2007 | 536.87 Million MYR | 23.2% |
| 2006 | 435.77 Million MYR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.23 Billion MYR | 0.43% |
| 2024 Q1 | 4.21 Billion MYR | -0.7% |
| 2023 Q2 | 4.17 Billion MYR | -0.07% |
| 2023 Q1 | 4.18 Billion MYR | -3.39% |
| 2023 Q4 | 4.24 Billion MYR | 1.02% |
| 2023 Q3 | 4.2 Billion MYR | 0.7% |
| 2023 FY | 4.24 Billion MYR | -1.79% |
| 2022 Q4 | 4.32 Billion MYR | -1.77% |
| 2022 Q2 | 4.5 Billion MYR | -8.35% |
| 2022 Q1 | 4.91 Billion MYR | -3.21% |
| 2022 FY | 4.32 Billion MYR | -14.82% |
| 2022 Q3 | 4.4 Billion MYR | -2.24% |
| 2021 Q3 | 5.48 Billion MYR | 3.97% |
| 2021 Q4 | 5.07 Billion MYR | -7.4% |
| 2021 Q1 | 4.5 Billion MYR | 24.04% |
| 2021 FY | 5.07 Billion MYR | 39.79% |
| 2021 Q2 | 5.27 Billion MYR | 17.06% |
| 2020 Q3 | 3.19 Billion MYR | 20.79% |
| 2020 Q1 | 2.43 Billion MYR | 2.64% |
| 2020 Q2 | 2.64 Billion MYR | 8.51% |
| 2020 Q4 | 3.63 Billion MYR | 13.63% |
| 2020 FY | 3.63 Billion MYR | 52.86% |
| 2019 FY | 2.37 Billion MYR | 10.66% |
| 2019 Q4 | 2.37 Billion MYR | 4.87% |
| 2019 Q1 | 2.17 Billion MYR | 1.09% |
| 2019 Q2 | 2.2 Billion MYR | 1.52% |
| 2019 Q3 | 2.26 Billion MYR | 2.82% |
| 2018 Q4 | 2.14 Billion MYR | 4.47% |
| 2018 Q3 | 2.05 Billion MYR | 0.76% |
| 2018 Q1 | 1.89 Billion MYR | 1.54% |
| 2018 FY | 2.14 Billion MYR | 15.18% |
| 2018 Q2 | 2.04 Billion MYR | 7.77% |
| 2017 Q1 | 1.64 Billion MYR | 6.25% |
| 2017 FY | 1.86 Billion MYR | 20.18% |
| 2017 Q4 | 1.86 Billion MYR | 8.41% |
| 2017 Q3 | 1.72 Billion MYR | 2.87% |
| 2017 Q2 | 1.67 Billion MYR | 1.42% |
| 2016 Q1 | 1.47 Billion MYR | -0.23% |
| 2016 FY | 1.55 Billion MYR | 5.12% |
| 2016 Q2 | 1.53 Billion MYR | 4.51% |
| 2016 Q3 | 1.5 Billion MYR | -2.39% |
| 2016 Q4 | 1.55 Billion MYR | 3.28% |
| 2015 Q2 | 1.34 Billion MYR | 4.07% |
| 2015 Q3 | 1.41 Billion MYR | 4.69% |
| 2015 Q4 | 1.47 Billion MYR | 4.53% |
| 2015 FY | 1.47 Billion MYR | 14.47% |
| 2015 Q1 | 1.29 Billion MYR | 0.52% |
| 2014 Q4 | 1.28 Billion MYR | 6.2% |
| 2014 Q1 | 1.15 Billion MYR | 4.17% |
| 2014 Q3 | 1.21 Billion MYR | 2.4% |
| 2014 Q2 | 1.18 Billion MYR | 2.93% |
| 2014 FY | 1.28 Billion MYR | 16.6% |
| 2013 Q1 | 1.01 Billion MYR | 2.5% |
| 2013 FY | 1.1 Billion MYR | 11.73% |
| 2013 Q4 | 1.1 Billion MYR | 5.03% |
| 2013 Q3 | 1.05 Billion MYR | 0.23% |
| 2013 Q2 | 1.05 Billion MYR | 3.54% |
| 2012 Q3 | 897.08 Million MYR | 2.39% |
| 2012 FY | 989.93 Million MYR | 21.85% |
| 2012 Q2 | 876.14 Million MYR | 5.34% |
| 2012 Q4 | 989.93 Million MYR | 10.35% |
| 2012 Q1 | 831.69 Million MYR | 0.0% |
| 2011 FY | 812.44 Million MYR | 4.52% |
| 2010 FY | 777.34 Million MYR | 12.9% |
| 2009 FY | 688.54 Million MYR | 5.33% |
| 2008 FY | 653.69 Million MYR | 21.76% |
| 2007 FY | 536.87 Million MYR | 23.2% |
| 2006 FY | 435.77 Million MYR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -231109.427% |
| Ansell Limited | 3.23 Billion USD | -31.306% |
| Ansell Limited | 3.24 Billion USD | -31.061% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -769.094% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -1414782.042% |
| Psykey, Inc. | 1.72 Million USD | -245926.769% |
| ConvaTec Group Plc | 3.7 Billion USD | -14.597% |
| ConvaTec Group Plc | 3.71 Billion USD | -14.435% |
| Encision Inc. | 3.81 Million USD | -111421.509% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -651823.894% |
| LifePoint, Inc. | 8.8 Million USD | -48142.542% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -26534.294% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -474734.413% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -77322.749% |
| Reflect Scientific, Inc. | 2.66 Million USD | -159132.763% |
| SmileDirectClub, Inc. | 597.06 Million USD | -611.779% |
| Sector 10, Inc. | 1000.00 USD | -424976700.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 10.46% |
| SheerVision, Inc. | 837.56 Thousand USD | -507295.605% |
| United Health Products, Inc. | 284.64 Thousand USD | -1492916.867% |
| Vasamed, Inc. | 1.6 Million USD | -265470.167% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -1904148.274% |
| Yubo International Biotech Limited | 2.34 Million USD | -180852.766% |